Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Castaman

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2008
New approaches in the measurement of coagulationJ Ingerslev, B Sørensen, G Castaman, et al.
Blood|April 1, 1996
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domainT Izumi, T Hashiguchi, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|November 16, 2018
The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTHM Makris, J Oldenburg, E P Mauser-Bunschoten, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
Successful use of recombinant FVIIa in combined factor V and FVIII deficiency with surgical bleeding resistant to substitutive treatment. A case reportI Di Marzio, O Iuliani, R Malizia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Inhibitors in haemophilia B: the Italian experienceG Castaman, E Bonetti, M Messina, et al.
Blood|October 6, 2001
TT virus contaminates first-generation recombinant factor VIII concentratesA Azzi, R De Santis, M Morfini, et al.
British Journal of Haematology|June 19, 2001
Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formationM Souri, V C Yee, K Kasai, et al.
Blood|November 15, 1989
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseP M Mannucci, A Lattuada, G Castaman, et al.
Blood|August 15, 1997
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotypeF Bernardi, E M Faioni, E Castoldi, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2012
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patientsG Castaman, A B Federici, A Tosetto, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2008
New approaches in the measurement of coagulationJ Ingerslev, B Sørensen, G Castaman, et al.
Blood|April 1, 1996
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domainT Izumi, T Hashiguchi, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|November 16, 2018
The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTHM Makris, J Oldenburg, E P Mauser-Bunschoten, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
Successful use of recombinant FVIIa in combined factor V and FVIII deficiency with surgical bleeding resistant to substitutive treatment. A case reportI Di Marzio, O Iuliani, R Malizia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Inhibitors in haemophilia B: the Italian experienceG Castaman, E Bonetti, M Messina, et al.
Blood|October 6, 2001
TT virus contaminates first-generation recombinant factor VIII concentratesA Azzi, R De Santis, M Morfini, et al.
British Journal of Haematology|June 19, 2001
Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formationM Souri, V C Yee, K Kasai, et al.
Blood|November 15, 1989
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseP M Mannucci, A Lattuada, G Castaman, et al.
Blood|August 15, 1997
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotypeF Bernardi, E M Faioni, E Castoldi, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2012
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patientsG Castaman, A B Federici, A Tosetto, et al.
Pageof 20